期刊文献+

糖尿病视网膜病变的治疗新进展 被引量:3

New advances in diabetic retinopathy treatment
下载PDF
导出
摘要 糖尿病视网膜病变(DR)是2型糖尿病中最为常见且严重的微血管并发症之一,同时也是导致患者失明的首要原因。它严重影响了人们的健康和生活质量,已经成为全人类关注的健康问题。DR早期发病隐匿且治疗效果欠佳,因此如何及早有效地防治DR成为研究的热点和难点。本文就近年来DR的治疗进展进行综述。 Diabetic retinopathy(DR)is one of the most common and severe microvascular complications of type 2 diabetes,and the leading cause of blind as well.It seriously affects people′s health and quality of life,which has gained more and more attention.In the early stage,DR doesn′t show any symptoms and the treatment is poor.Therefore,it is the hot research topic how to treat DR effectively as soon as possible.This paper is the review of recent advances in diabetic retinopathy treatment.
作者 李亚利 陈莉莉 LI Ya-li;CHEN Li-li(Jishou University School of Medicine,Jishou,Hunan416000,China;Department of Endocrinology,People′s Hospital of Xiangxi Autonomous Prefecture,Hunan Province,Jishou416000,China)
出处 《中国当代医药》 2020年第13期33-36,共4页 China Modern Medicine
关键词 糖尿病视网膜病变 抗VEGF药物 激光光凝术 基因治疗 Diabetic retinopathy Anti-VEGF drugs Laser photocoagulation Gene therapy
  • 相关文献

参考文献23

二级参考文献123

共引文献469

同被引文献63

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部